While its not an official diagnostic label, the term captures a clear clinical phenomenon: the depletion of the faces natural fat compartments when the body undergoes swift, significant fat loss
5.3 Ferroptosis-targeted therapeutic strategies in coronary heart disease 5.3.1 Inhibiting ferroptosis in coronary atherosclerotic plaques The pathogenesis of coronary atherosclerotic plaques involves iron accumulation and lipid peroxidationhallmarks of ferroptosis
How could carnitine deficiency lead to a form of autism in an apparently healthy infant
Moving from insulin to GLP-1 A patient on basal insulin whose Type 2 diabetes is relatively well controlled might transition to a GLP-1 agonist if they are gaining excessive weight on insulin, want to simplify their regimen, have developed cardiovascular risk factors that would benefit from GLP-1 protection, or have adequate remaining beta cell function
Unlike oral supplements, injections bypass the digestive tract, potentially allowing for better absorption